当前位置: 首页 > 期刊 > 《医学信息》 > 2023年第15期
编号:2333341
整合素在肝癌中的作用机制
http://www.100md.com 2023年12月29日 医学信息 2023年第15期
     摘要:原发性肝细胞性肝癌是全球最常见的恶性肿瘤,因其具有较高的恶性程度、转移率、复发率和死亡率,对患者生存预后造成了严重影响。整合素参与众多肿瘤的生长、侵袭、转移和血管生成,逐渐成为研究肝癌的热门靶点。探索整合素在肝癌发病机制中的作用,利用整合素探针进行靶向诊断和治疗,可有效降低肝癌的死亡率。本文就整合素在肝癌中的作用机制进行综述,以期为肝癌的研究及治疗提供参考。

    关键词:肝癌;整合素;靶向诊断;靶向治疗

    中图分类号:R282.71" " " " " " " " " " " " " " " " "文献标识码:A" " " " " " " " " " " " " " " "DOI:10.3969/j.issn.1006-1959.2023.15.040

    文章编号:1006-1959(2023)15-0183-05

    The Mechanism of Integrin in Liver Cancer

    LIU Yu-xin1,LI Hua2,LIU Lei1,SHEN Ting-yun1,DAI Wei3

    (1.The First Clinical Medical College of Guangdong Medical University,Zhanjiang 524000,Guangdong,China;

    2.Department of Obstetrics and Gynecology,Maoming People's Hospital,Maoming 525000,Guangdong,China;

    3.Department of Hepatobiliary Surgery,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,China)

    Abstract:Primary hepatocellular carcinoma is the most common malignant tumor in the world. Because of its high malignancy, metastasis rate, recurrence rate and mortality, it has a serious impact on the survival and prognosis of patients. Integrin is involved in the growth ......

您现在查看是摘要页,全文长 20558 字符